Cargando…

S1P signaling: new therapies and opportunities

Development of sphingosine-1-phosphate receptor 1 (S1P(1)) modulators to dampen inflammation and its sequelae is becoming increasingly promising for treating medical conditions characterized by significant immunopathology. As shown by the non-selective S1P receptor modulator FTY720 (fingolimod [Gile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Cabrera, Pedro J., Brown, Steve, Studer, Sean M., Rosen, Hugh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Faculty of 1000 Ltd 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251414/ https://www.ncbi.nlm.nih.gov/pubmed/25580263 http://dx.doi.org/10.12703/P6-109

Ejemplares similares

MET Signaling Pathways, Resistance Mechanisms, and Opportunities for Target Therapies
por: Rivas, Solange, et al.
Publicado: (2022)

Actions of a picomolar short-acting S1P(1) agonist in S1P(1)-eGFP knock-in mice
por: Cahalan, Stuart M., et al.
Publicado: (2011)

A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
por: Park, Woo-Jung, et al.
Publicado: (2023)

Precision Therapy for Mesothelioma: Feasibility and New Opportunities
por: Dulloo, Sean, et al.
Publicado: (2021)

P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
por: Zhang, Ding-Guo, et al.
Publicado: (2014)

Estrogen Signaling in Lung Cancer: An Opportunity for Novel Therapy
por: Baik, Christina S., et al.
Publicado: (2012)

Epigenetics of Autoantigens: New Opportunities for Therapy of Autoimmune Diseases
por: Radic, Marko, et al.
Publicado: (2013)

Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
por: Laface, Carmelo, et al.
Publicado: (2022)

Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
por: Pastor-Fernández, Gloria, et al.
Publicado: (2020)

Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities
por: Kim, Tae Wan, et al.
Publicado: (2020)

A Review on VCII Applications in Signal Conditioning for Sensors and Bioelectrical Signals: New Opportunities
por: Safari, Leila, et al.
Publicado: (2022)

Notch signals in the endothelium and cancer "stem-like" cells: opportunities for cancer therapy
por: Gu, Jian-Wei, et al.
Publicado: (2012)

Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
por: Stoykova, Gergana E., et al.
Publicado: (2019)

Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications
por: Grund-Gröschke, Sandra, et al.
Publicado: (2019)

Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities
por: Cunha, Pedro, et al.
Publicado: (2011)

Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions
por: Zhang, Linda S., et al.
Publicado: (2016)

The Biology of Glial Cells and Their Complex Roles in Alzheimer’s Disease: New Opportunities in Therapy
por: Nirzhor, Saif Shahriar Rahman, et al.
Publicado: (2018)

Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
por: Lima, Priscila A., et al.
Publicado: (2022)

Emerging Opportunities for Synthetic Biology in Agriculture
por: Goold, Hugh Douglas, et al.
Publicado: (2018)

Adenovirus as a new agent for multiple myeloma therapies: Opportunities and restrictions
por: Raus, Svjetlana, et al.
Publicado: (2011)

Prostaglandin Pathways: Opportunities for Cancer Prevention and Therapy
por: Wang, Qiushi, et al.
Publicado: (2022)

Opportunities for organoids as new models of aging
por: Hu, Jennifer L., et al.
Publicado: (2018)

Monitoring Proteolytic Activity in Real Time: A New World of Opportunities for Biosensors
por: Oliveira-Silva, Rui, et al.
Publicado: (2020)

The IGF1 Signaling Pathway: From Basic Concepts to Therapeutic Opportunities
por: Werner, Haim
Publicado: (2023)

New Opportunities in Glycan Engineering for Therapeutic Proteins
por: Zhong, Xiaotian, et al.
Publicado: (2022)

Death Receptors: New Opportunities in Cancer Therapy.
por: Ukrainskaya, V.M., et al.
Publicado: (2017)

Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy
por: Dufait, Inès, et al.
Publicado: (2016)

Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities
por: Bansod, Sapana, et al.
Publicado: (2021)

Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology
por: Leroux, Cédric, et al.
Publicado: (2021)

Regulation of Inflammasome by microRNAs in Triple-Negative Breast Cancer: New Opportunities for Therapy
por: (Stămat), Liliana-Roxana Balahura, et al.
Publicado: (2023)

Cytokine signalling: new insights and new opportunities for therapeutic intervention?
por: O'Shea, JJ
Publicado: (2001)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
por: Sychev, Dmitrij A, et al.
Publicado: (2018)

Barriers and opportunities for gemcitabine in pancreatic cancer therapy
por: Beutel, Alica K., et al.
Publicado: (2023)

Sphingosine-1-phosphate receptor-1 (S1P(1)) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease
por: Karuppuchamy, Thangaraj, et al.
Publicado: (2016)

New opportunities for nanoparticles in cancer immunotherapy
por: Park, Wooram, et al.
Publicado: (2018)

Pancreatic Cancer: Challenges and Opportunities in Locoregional Therapies
por: Bazeed, Alaa Y., et al.
Publicado: (2022)

Proton Therapy for Prostate Cancer: Challenges and Opportunities
por: Poon, Darren M. C., et al.
Publicado: (2022)

Molecular and Cellular Therapies: New challenges and opportunities
por: Wang, Xiangdong, et al.
Publicado: (2013)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Signal transducer and activator of transcription 6 as a target in colon cancer therapy
por: Delgado-Ramirez, Yael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p1fio38s8lel6erlt8i0c4nmgi